Clinical Trials Directory

Trials / Completed

CompletedNCT06993948

Hyperdynamic Left Ventricular Ejection Fraction as a Predictor of Mortality in Intensive Care Unit Patients With Septic Shock

Status
Completed
Phase
Study type
Observational
Enrollment
235 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study aimed to evaluate the cause and prognosis of hyperdynamic left ventricular ejection fraction in critically ill patients with sepsis.

Detailed description

Cardiovascular dysfunction is increasingly being recognized as a significant complication in sepsis, affecting patient outcomes. Among the key parameters used to evaluate cardiac performance is the left ventricular ejection fraction (LVEF), typically assessed via transthoracic echocardiography (TTE). LVEF has been extensively studied; most investigations into preserved ejection fraction tend to group all values ≥50% together, thereby overlooking the potential clinical implications of LVEF ≥70%, often referred to as hyperdynamic LVEF (HDLVEF).

Conditions

Interventions

TypeNameDescription
DEVICETransthoracic echocardiographyTransthoracic echocardiography (TTE) was carried out. The assessment of left ventricular ejection fraction (LVEF) relied primarily on two-dimensional echocardiography using visual estimation.

Timeline

Start date
2022-08-01
Primary completion
2023-07-01
Completion
2023-07-01
First posted
2025-05-29
Last updated
2025-05-29

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06993948. Inclusion in this directory is not an endorsement.